Measurement of lysosomal glucocerebrosidase activity in mouse liver using a fluorescence-activated cell sorter assay

Analytical Biochemistry

Volumn 334, Issue 2, 2004, Pages 227-233

  Chan, Katherine Watt ^a,b   Waire, James ^a   Simons, Betsy ^a   Karey, Ken ^a   Fung, John ^a   Copeland, Diane ^a   Andrews, Laura ^a  

^a GENZYME CORPORATION   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; FLUORESCENCE; LIVER; MACROPHAGES; MAMMALS; MONOCLONAL ANTIBODIES; PATIENT MONITORING; PATIENT TREATMENT; PHYSIOLOGICAL MODELS; TISSUE; TISSUE CULTURE;

CELLULAR LOCALIZATION; COMBINED MEASUREMENTS; ENZYME REPLACEMENT THERAPY; FLOW CYTOMETRIC MEASUREMENT; FLUORESCENCE-ACTIVATED CELL SORTERS; MOLECULES OF EQUIVALENT SOLUBLE FLUOROPHORES; NONPARENCHYMAL CELLS; QUANTITATIVE METHOD;

ENZYME ACTIVITY;

FLUORESCEIN; GLUCOSYLCERAMIDASE; MONOCLONAL ANTIBODY; PHYCOERYTHRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; KUPFFER CELL; LIVER; LYSOSOME; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALIA;

EID: 5644246312     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2004.08.031     Document Type: Article

References (17)

1. E. Beutler, and G.A. Grabowski Gaucher disease C.R. Scriver A.C. Beaudet W.S. Sly D. Valle The Metabolic and Molecular Bases of Inherited Disease Eighth ed. 2001 McGraw-Hill New York 3635 3668
2. B. Friedman, K. Vaddi, C. Preston, E. Mahon, J.R. Cataldo, and J.M. McPherson A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived β-glucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease Blood 93 1999 2807 2816
3. G.A. Grabowski Current issues in enzyme therapy for Gaucher disease Drugs 52 1996 159 167
4. N.W. Barton, R.O. Brady, J.M. Dambrosia, A.M. Di Bisceglie, S.H. Doppelt, S.C. Hill, H.J. Mankin, G.J. Murray, R.I. Parker, C.E. Argoff, R.P. Grewal, and K.-T. Yu Replacement therapy for inherited enzyme deficiency: macrophage targeted glucocerebrosidase for Gaucher's disease N. Engl. J. Med. 324 1991 1464 1470
5. Y. Sato, and E. Beutler Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages J. Clin. Invest. 91 1993 1909 1917
6. M.K. Bijsterbosch, W. Donker, H. Van De Bilt, S. Van Weely, T.J.C. Van Berkel, and J.M.F.G. Aerts Quantitative analysis of the targeting of mannose-terminal glucocerebrosidase predominant uptake by liver endothelial cells Eur. J. Biochem. 237 1996 344 349
7. + cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation Hum. Gene Ther. 9 1998 2629 2640
8. C. Dunbar, and D. Kohn Retroviral mediated transfer of the cDNA for human glucocerebrosidase into hematopoietic stem cells of patients with Gaucher disease Hum. Gene Ther. 7 1996 231 253
9. + cells and corrects the enzyme deficiency in cells from Gaucher patients Blood 87 1996 1754 1762
10. M.J.E. Havenga, A.B. Werner, D. Valerio, and H.H.G. van Es A flow cytometric assay enabling specific detection of the human lysosomal enzyme, β-glucocerebrosidase Anal. Biochem. 262 1998 57 66
11. H.H.G. van Es, M. Veldwijk, M. Havenga, and D. Valerio A flow cytometric assay for lysosomal glucocerebrosidase Anal. Biochem. 247 1997 268 271
12. M. Lorincz, L.A. Herzenberg, Z. Diwu, J.A. Barranger, and W.G. Kerr Detection and isolation of gene-corrected cells in Gaucher disease via a fluorescence-activated cell sorter assay for lysosomal glucocerebrosidase activity Blood 89 1997 3412 3420
13. B. Rudensky, E. Paz, G. Altharescu, D. Raveh, D. Elstein, and A. Zimran Fluorescent flow cytometric assay: a new diagnostic tool for measuring β-gluocerebrosidase activity in Gaucher disease Blood Cells Mol. Dis. 30 2002 97 99
14. A.K. Gaigalas, L. Li, O. Henderson, R. Vogt, J. Barr, G. Marti, J. Weaver, and A. Schwartz The development of fluorescence intensity standards J. Res. Natl. Inst. Stand. Technol. 106 2001 381 389
15. M. Adachi, and B. Volk Gaucher disease in mice induced by conduritol-β-epoxide Arch. Pathol. Lab. Med. 101 1977 255 259
16. M.C. Stephens, A. Bernatsky, V. Burachinsky, G. Legler, and J.N. Kanfer The Gaucher mouse: differential action of conduritol β epoxide and reversibility of its effect J. Neurochem. 30 1978 1023 1027
17. G. Alpini, J.O. Phillips, B. Vroman, and N.F. LaRusso Recent advances in the isolation of liver cells Hepatology 20 1994 494 514